|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/22 | (2006.01) |
| C07K 16/24 | (2006.01) |
| (11) | Number of the document | 3241843 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17161990.1 |
| Date of filing the European patent application | 2009-06-25 | |
| (97) | Date of publication of the European application | 2017-11-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-28 |
| (46) | Date of publication of the claims translation | 2021-09-27 |
| (30) | Number | Date | Country code |
| 75692 P | 2008-06-25 | US |
| (72) |
BORRAS, Leonardo , CH
URECH, David , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Imuninių rišiklių tirpumo optimizavimas |
| SOLUBILITY OPTIMIZATION OF IMMUNOBINDERS |
| Payment date | Validity (years) | Amount | |
| 2025-05-22 | 17 | 347.00 EUR |
| 2026-06-25 |